Netsync Network Solutions achieves Telehealth Authorized Technology Provider status from Cisco

NewsGuard 100/100 Score

Netsync Network Solutions announced today that it has achieved Telehealth Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Netsync Network Solutions as having fulfilled the training requirements and program prerequisites to sell, deploy and support Cisco Telehealth solutions.

Cisco Telehealth helps partners enhance the delivery of health care at a distance. Cisco Telehealth ATP Partners deliver solutions that are designed to provide improved access to health services, reduced patient wait times, and decreased travel time and costs for patients and providers. The goal of the program is to help partners deliver an immersive and personalized experience for patient and clinician consultations to customers in underserved and hard-to-reach communities.

"We at Netsync are excited to achieve this Cisco Telehealth ATP designation," said Mike Griffin, Collaboration Practice Manager. "Cisco's Telehealth collaboration platform transforms the clinician experience by delivering interactive visual communications between patients and remote healthcare providers at any time, from anywhere. With this collaboration platform, we are able to assist our clients in the healthcare industry to improve continuity of care, outcomes, and satisfaction and make highly skilled healthcare providers more accessible."

The Cisco Authorized Technology Provider (ATP) Program is part of the Cisco go-to-market strategy for emerging technologies. The program helps Cisco to define the knowledge, skills and services that channel partners need to successfully sell, deploy and support an emerging technology. As the market changes, an ATP designation may be discontinued or may evolve into a Cisco specialization.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New tARC-seq method enhances precision in tracking SARS-CoV-2 mutations